FDA Warning Letter — Bio-Medical Pharmaceutical Manufacturing Corporation
The FDA took a Warning Letter action against Bio-Medical Pharmaceutical Manufacturing Corporation on February 5, 2026 (Houston, TX). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Bio-Medical Pharmaceutical Manufacturing Corporation
- Date
- February 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Houston, TX (United States)